LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Effects of adalimumab and secukinumab on comorbidities associated with metabolism in patients with plaque psoriasis

Photo by sharonmccutcheon from unsplash

To the Editor: Psoriasis is often associated with comorbidities such as cardiovascular diseases, obesity, and metabolic syndrome (MS). However, the prevalence of abovementioned diseases in Chinese patients with plaque psoriasis… Click to show full abstract

To the Editor: Psoriasis is often associated with comorbidities such as cardiovascular diseases, obesity, and metabolic syndrome (MS). However, the prevalence of abovementioned diseases in Chinese patients with plaque psoriasis is still unknown. Recently, biologics such as tumor necrosis alpha inhibitors, interleukin-17A inhibitors have been successfully used in the treatment of plaque psoriasis. However, the effects of biological treatment on comorbidities associated with metabolism are still controversial. Study on the relationship between the comorbidities associated with metabolism and plaque psoriasis and the effects of biologics are necessary.

Keywords: associated metabolism; patients plaque; plaque psoriasis; psoriasis; comorbidities associated

Journal Title: Chinese Medical Journal
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.